Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : MW-III
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Study Phase : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
Details : MW-III is a Other Small Molecule drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Burns.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
February 16, 2011
Lead Product(s) : MW-III
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Sesame Oil
Therapeutic Area : Podiatry
Study Phase : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Sesame Oil is a drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Diabetic Foot.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
June 30, 2010
Lead Product(s) : Sesame Oil
Therapeutic Area : Podiatry
Highest Development Status : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Sesame Oil
Therapeutic Area : Gastroenterology
Study Phase : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Sesame Oil is a drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Ulcer.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
June 07, 2010
Lead Product(s) : Sesame Oil
Therapeutic Area : Gastroenterology
Highest Development Status : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Sesame Oil
Therapeutic Area : Podiatry
Study Phase : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Sesame Oil is a drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Diabetic Foot.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
February 18, 2010
Lead Product(s) : Sesame Oil
Therapeutic Area : Podiatry
Highest Development Status : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
